These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28458469)

  • 1. TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes.
    Ryu J; Lee JW
    Mediators Inflamm; 2017; 2017():5108525. PubMed ID: 28458469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
    Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
    FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane 4 L Six Family Member 5 (TM4SF5)-Mediated Epithelial-Mesenchymal Transition in Liver Diseases.
    Lee JW
    Int Rev Cell Mol Biol; 2015; 319():141-63. PubMed ID: 26404468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition.
    Kang M; Choi S; Jeong SJ; Lee SA; Kwak TK; Kim H; Jung O; Lee MS; Ko Y; Ryu J; Choi YJ; Jeong D; Lee HJ; Ye SK; Kim SH; Lee JW
    Biochem J; 2012 May; 443(3):691-700. PubMed ID: 22292774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities.
    Kang M; Ryu J; Lee D; Lee MS; Kim HJ; Nam SH; Song HE; Choi J; Lee GH; Kim TY; Lee H; Kim SJ; Ye SK; Kim S; Lee JW
    PLoS One; 2014; 9(7):e102817. PubMed ID: 25033048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
    Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
    Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors.
    Choi J; Kang M; Nam SH; Lee GH; Kim HJ; Ryu J; Cheong JG; Jung JW; Kim TY; Lee HY; Lee JW
    Lung Cancer; 2015 Oct; 90(1):22-31. PubMed ID: 26190015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2- and 3-dimensional environments.
    Kim HJ; Kwon S; Nam SH; Jung JW; Kang M; Ryu J; Kim JE; Cheong JG; Cho CY; Kim S; Song DG; Kim YN; Kim TY; Jung MK; Lee KM; Pack CG; Lee JW
    FASEB J; 2017 Apr; 31(4):1461-1481. PubMed ID: 28073834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of transmembrane 4 L six family member 5 (TM4SF5)-mediated tumorigenesis by TSAHC and sorafenib.
    Lee SA; Lee MS; Ryu HW; Kwak TK; Kim H; Kang M; Jung O; Kim HJ; Park KH; Lee JW
    Cancer Biol Ther; 2011 Feb; 11(3):330-6. PubMed ID: 21099346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes.
    Sun H; Kim E; Ryu J; Lee H; Shin EA; Lee M; Lee H; Lee JH; Yoon JH; Song DG; Kim S; Lee JW
    Cell Mol Life Sci; 2021 Dec; 79(1):49. PubMed ID: 34921636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition.
    Lee MS; Kim HP; Kim TY; Lee JW
    Biochim Biophys Acta; 2012 Feb; 1823(2):514-23. PubMed ID: 22178131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation.
    Jung O; Choi YJ; Kwak TK; Kang M; Lee MS; Ryu J; Kim HJ; Lee JW
    Biochim Biophys Acta; 2013 Mar; 1833(3):629-42. PubMed ID: 23220047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
    Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
    J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment.
    Lee SA; Kim YM; Kwak TK; Kim HJ; Kim S; Ko W; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
    Carcinogenesis; 2009 Nov; 30(11):1872-9. PubMed ID: 19789264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of signaling between TM4SF5 and integrins in tumor microenvironment.
    Lee SA; Park KH; Lee JW
    Front Biosci (Landmark Ed); 2011 Jan; 16(5):1752-8. PubMed ID: 21196261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid transporters as tetraspanin TM4SF5 binding partners.
    Jung JW; Kim JE; Kim E; Lee JW
    Exp Mol Med; 2020 Jan; 52(1):7-14. PubMed ID: 31956272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TM4SF5 suppression disturbs integrin α5-related signalling and muscle development in zebrafish.
    Choi YJ; Kim HH; Kim JG; Kim HJ; Kang M; Lee MS; Ryu J; Song HE; Nam SH; Lee D; Kim KW; Lee JW
    Biochem J; 2014 Aug; 462(1):89-101. PubMed ID: 24897542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TM4SF5-mediated protein-protein networks and tumorigenic roles.
    Lee JW
    BMB Rep; 2014 Sep; 47(9):483-7. PubMed ID: 25027595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity.
    Kim H; Kang M; Lee SA; Kwak TK; Jung O; Lee HJ; Kim SH; Lee JW
    Biochim Biophys Acta; 2010 Aug; 1803(8):975-82. PubMed ID: 20399237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
    Lee D; Na J; Ryu J; Kim HJ; Nam SH; Kang M; Jung JW; Lee MS; Song HE; Choi J; Lee GH; Kim TY; Chung JK; Park KH; Kim SH; Kim H; Seo H; Kim P; Youn H; Lee JW
    Hepatology; 2015 Jun; 61(6):1978-97. PubMed ID: 25627085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.